Global CDK 4/6 Inhibitor Drugs Market to Witness Remarkable Growth, Backed by Growing Incidences of Breast Cancer Worldwide; Market to Generate a Soaring Revenue of USD 42511.38 Million by 2030 New York, Jan. 27, 2022 (GLOBE NEWSWIRE) -- According to the statistics by the World Health Organization (WHO), the total number of women diagnosed with breast cancer around the globe in the year...

Tumor Necrosis Factor Inhibitor Drugs Market Size Worth US$ 41 Bn by 2026 LOS ANGELES, July 19, 2019 (GLOBE NEWSWIRE) -- The global TNF inhibitor drugs market is estimated to grow at CAGR above 0.6% over the forecast time frame 2019 to 2026 and reach the market value...